Entrada Therapeutics

TRDA

Entrada Therapeutics has been a target of short sellers for a while. The current short interest of 8.40% is significantly above the average of the last 12 months (4.02%).

Short Interest Trend

Share Price

Total NSP

8.40%

+0.72%

vs. last month

Also interesting? All insider buys at Entrada Therapeutics

Found an error? Questions? Ideas?